The 2021 Medtech Contract Manufacturing Report

innovation hub

NanoCor Therapeutics is Profiled in this Database

Updated At 20 Aug, 2010

Start Free 7 Day Trial Now
Partial description of this company
First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF)

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NanoCor Therapeutics plus 4842 other startups.

Start Free 7 Day Trial Now

Learn More About NanoCor Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients